
Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.
Jon Sutch, PhD, is manager of formulation development at Patheon’s Milton Park facility, UK, jon.sutch@patheon.com.

Published: August 1st 2014 | Updated: